Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells

Life Sciences

Volumn 80, Issue 22, 2007, Pages 2051-2059

  Chou, Chih Chung ^a   Yung, Benjamin Yat Ming ^b   Hsu, Chen Ya ^a  

^a FOOYIN UNIVERSITY   (Taiwan)

^b Genomics Research Center   (Taiwan)

Author keywords

Megakaryocytic differentiation; Nucleolin; Nucleophosmin B23

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; NUCLEOPHOSMIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEASOME INHIBITOR; PROTEIN KINASE C;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN K 562; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MEGAKARYOCYTE; MYELOID LEUKEMIA; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

CARBAZOLES; CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; INDOLES; K562 CELLS; LEUKEMIA, MYELOID; MALEIMIDES; MEGAKARYOCYTES; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE C; RNA-BINDING PROTEINS; TETRADECANOYLPHORBOL ACETATE;

EID: 34247890045     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.03.004     Document Type: Article

References (51)

1. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., and Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. Journal of Biological Chemistry 270 (1995) 27489-27494
2. Alitalo R. Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts. Leukemia Research 14 (1990) 501-514
3. Bouschet T., Perez V., Fernandez C., Bockaert J., and Eychene A. Stimulation of the ERK pathway by GTP-loaded Rap1 requires the concomitant activation of Ras, protein kinase C and protein kinase A in neuronal cells. Journal of Biological Chemistry 278 (2003) 4778-4785
4. Bush H., Byvoet P., and Smetana K. The nucleolus of the cancer cell. Cancer Research 23 (1963) 313-339
5. Chan W.Y., Liu Q.R., Borjigin J., Busch H., Rennert O.M., Tease L.A., and Chan P.K. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28 (1989) 1033-1039
6. Chen C.M., Chiang S.Y., and Yeh N.H. Increased stability of nucleolin in proliferating cells by inhibition of its self-cleaving activity. Journal of Biological Chemistry 266 (1991) 7754-7758
7. Chou C.C., and Yung B.Y.M. Increased stability of nucleophosmin/B23 in anti-apoptotic effect of ras during serum deprivation. Molecular Pharmacology 59 (2001) 38-45
8. Dalton W.S. The proteasome. Seminars in Oncology 31 6 Suppl 16 (2004) 3-9
9. Dekker L.V., and Parker P.J. Protein kinase C question of specificity. Trends in Biochemical Sciences 19 (1994) 73-77
10. del Rincon S.V., Guo Q., Morelli C., Shiu H.Y., Sumacz E., and Miller W.H. Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependant mechanism. Oncogene 23 (2004) 9269-9279
11. Delehanty L.L., Mogass M., Gonias S.L., Racke F.K., Johnstone B., and Goldfarb A.N. Stromal inhibition of megakaryocytic differentiation is associated with blockade of sustained Rap1 activation. Blood 101 (2003) 1744-1751
12. Derenzini M. The AgNORs. Micron 31 (2000) 117-120
13. Derenzini M., Sirri V., Trere D., and Ochs R.L. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Laboratory Investigation 73 (1995) 497-502
14. Dudley D.T., Pang L., Decker S.J., Bridges A.J., and Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proceedings of the National Academy of Sciences of the United States of America 92 (1995) 7686-7689
15. Falini B., Mecucci C., Tiacci E., Alcalay M., Rosati R., Pasqualucci L., La Starza R., Diverio D., Colombo E., Santucci A., Bigerna B., Pacini R., Pucciarini A., Liso A., Vignetti M., Fazi P., Meani N., Pettirossi V., Saglio G., Mandelli F., Lo-Coco F., Pelicci P.G., and Martelli M.F. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. New England Journal of Medicine 352 (2005) 1819-1820
16. Fang S.H., and Yeh N.H. The self-cleaving activity of nucleolin determines its molecular dynamics in relation to cell proliferation. Experimental Cell Research 208 (1993) 48-53
17. Feuerstein N., and Mond J.J. "Numatrin", a nuclear matrix protein associated with induction of proliferation in B lymphocytes. Journal of Biological Chemistry 262 (1987) 11389-11397
18. Feuerstein N., Spiegel S., and Mond J.J. The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody. Journal of Cell Biology 107 (1988) 1629-1642
19. Gewirtz A.M., Burger D., Rado T.A., Benz E.J., and Hoffman R. Constitutive expression of platelet glycoproteins by the human leukemia cell line K562. Blood 60 (1982) 785-789
20. Goldberg A.L., Akopian T.N., Kisselev A.F., Lee D.H., and Rohwild M. New insights into the mechanisms and importance of the proteasome in intracellular protein degradation. Biological Chemistry 378 (1997) 131-140
21. Hsu C.Y., and Yung B.Y.M. Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells. Oncogene 16 (1998) 915-923
22. Hsu C.Y., and Yung B.Y.M. Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis. International Journal of Cancer 88 (2000) 392-400
23. Hsu C.Y., and Yung B.Y.M. Involvement of nucleophosmin/B23 in TPA-induced megakaryocytic differentiation of K562 cells. British Journal of Cancer 89 (2003) 1320-1326
24. Hug H., and Sarre T.F. Protein kinase C isozymes-divergence in signal transduction. Biochemical Journal 291 (1993) 329-343
25. Itahana K., Bhat K.P., Jin A., Itahana Y., Hawke D., Kobayashi R., and Zhang Y. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Molecular Cell 12 (2003) 1151-1164
26. Jelinek T., Catling A.D., Reuter C.W., Moodie S.A., Wolfman A., and Weber M.J. RAS and RAF-1 form a signallig complex with MEK-1 but not MEK-2. Molecular and Cellular Biology 14 (1994) 8212-8218
27. Kambhampati S., Li Y., Verma A., Sassano A., Majchrzak B., Deb D.K., Parmar S., Giafis N., Kalvakolanu D.V., Rahman A., and Platanias L.C. Activation of protein kinase Cδ by all-trans-retinoic acid. Journal of Biological Chemistry 278 (2003) 32544-32551
28. Kondo T., Minamino N., Nagamura-Inoue T., Matsumoto M., Taniguchi T., and Tanaka N. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene 15 (1997) 1275-1281
29. Korgaonkar C., Hagen J., Tompkins V., Frazier A.A., Allamargot C., Quelle F.W., and Quelle D.E. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Molecular and Cellular Biology 25 (2005) 1258-1271
30. Liu W.H., and Yung B.Y.M. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23. Oncogene 17 (1998) 3055-3064
31. Liu H.T., and Yung B.Y.M. In vivo interaction of nucleophosmin/B23 and protein C23 during cell cycle progression in HeLa cells. Cancer Letters 144 (1999) 45-54
32. Long M.W., Smolen J.E., Szczepanski P., and Boxer L.A. Role of phorbol diesters in vitro murine megakaryocyte colony formation. Journal of Clinical Investigation 74 (1984) 1686-1692
33. Long M.W., Heffner C.H., Williams J.L., Peters C., and Prochownik E.V. Regulation of megakaryocyte phenotype in human erythroleukemia cells. Journal of Clinical Investigation 85 (1990) 1072-1084
34. Lumelsky N.L., and Schwartz B.S. Protein kinase C in erythroid and megakaryocytic differentiation: possible role in lineage determination. Biochimica et Biophysica Acta 1358 (1997) 79-92
35. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., Marme D., and Schachtele C. Selective inhibition of protein kinase C isozymes by the Indolocarbazole Gö 6976. Journal of Biological Chemistry 268 (1993) 9194-9197
36. Murakami T., Ohmori H., Gotoh S., Tsuda T., Ohya R., Akiya S., and Higashi K. Down modulation of N-myc, heat-shock protein 70 and nucleolin during the differentiation of human neuroblastoma cells. Journal of Biochemistry 110 (1991) 146-150
37. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258 (1992) 607-614
38. Pederson T. The plurifunctional nucleolus. Nucleic Acids Research 26 (1998) 3871-3876
39. Racke F.K., Lewandowska K., Goueli S., and Goldfarb A.N. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. Journal of Biological Chemistry 272 (1997) 23366-23370
40. Racke F.K., Wang D., Zaidi Z., Kelley J., Visvader J., Soh J.W., and Goldfrb A.N. A potential role for protein kinase C-ε in regulating megakaryocytic lineage commitment. Journal of Biological Chemistry 276 (2001) 522-528
41. Scheer U., and Weisenberger D. The nucleolus. Current Opinion in Cell Biology 6 (1994) 354-359
42. Scheer U., Thiry M., and Goessens G. Structure, function and assembly of the nucleolus. Trends in Cell Biology 3 (1993) 236-241
43. Schonwasser D.C., Marais R.M., Marshall C.J., and Parker P.J. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Molecular and Cellular Biology 18 (1998) 790-798
44. Shimbara N., Orino E., Sone S., Ogura T., Takashina M., Shono M., Tamura T., Yasuda H., Tanaka K., and Ichihara A. Regulation of gene expression of proteasomes (multi-protease complexes) during growth and differentiation of human hematopoietic cells. Journal of Biological Chemistry 267 (1992) 18100-18109
45. Sommerville J. Nucleolar structure and ribosome biogenesis. Trends in Biochemical Sciences 11 (1986) 438-442
46. Spataro V., Norbury C., and Harris A.L. The ubiquitin-proteasome pathway in cancer. British Journal of Cancer 77 (1998) 448-455
47. Tabilio A., Pelicci P.G., Vinci G., Mannoni P., Civin C.I., Vainchenker W., Testa U., Lipinski M., Rochant H., and Breton-Gorius J. Myeloid and megakaryocytic properties of K562 cell lines. Cancer Research 43 (1983) 4569-4574
48. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriollet F., Duhame L., Charon D., and Kirilovsky J. The Bisindolylmaleimide GF109203X is a potent and selective inhibitor of protein kinase C. Journal of Biological Chemistry 266 (1991) 15771-15781
49. Tuteja R., and Tuteja N. Nucleolin: a multifunctional major nucleolar phosphoprotein. Critical Reviews in Biochemistry and Molecular Biology 33 (1998) 407-436
50. Ueda Y., Hirai S., Osada S., Suzuki A., Mizuno K., and Ohno S. Protein kinase C δ activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. Journal of Biological Chemistry 271 (1996) 23512-23519
51. Wyke S.M., and Tisdale M.J. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway. Life Sciences 78 (2006) 2898-2910